| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 848,728 | 786,920 | 1,054,607 | 1,431,642 | | Cost of Revenue | 773,606 | 741,457 | 909,543 | 1,099,232 | | | Gross Profit | 75,122 | 45,463 | 145,064 | 332,410 | | | Operating Expenses | | Research Development | 16,133 | 15,922 | 17,095 | 17,120 | | Selling General and Administrative | 86,028 | 62,158 | 45,928 | 94,861 | | Non Recurring | (33,806) | 9,706 | 24,072 | 28 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,773) | (42,323) | 57,969 | 220,401 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (26,826) | (595) | 876 | 5,146 | | Earnings Before Interest And Taxes | (11,711) | (46,639) | 57,397 | 222,368 | | Interest Expense | 6,682 | 7,075 | 7,410 | 6,081 | | Income Before Tax | (18,393) | (53,714) | 49,987 | 216,287 | | Income Tax Expense | (24,474) | (21,378) | 6,999 | 67,049 | | Minority Interest | 8,348 | (3,721) | (1,448) | (3,179) | | | | Net Income From Continuing Ops | 6,081 | (32,336) | 42,988 | 149,238 | | | Non-recurring Events | | Discontinued Operations | (16,028) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,947) | (32,336) | 42,988 | 149,238 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,947) | ($32,336) | $42,988 | $149,238 |
|
0.01% Nasdaq 
0.22%
Income Statement
